Omega-3脂肪酸市場商機、成長要素、產業趨勢分析及2026-2035年預測。

全球 omega-3 脂肪酸市場預計到 2025 年將價值 35 億美元，預計到 2035 年將以 4.1% 的複合年成長率成長至 52 億美元。

隨著消費者對ω-3脂肪酸健康益處的認知不斷提高，ω-3脂肪酸市場持續擴張。人們對預防醫學、膳食補充劑和整體健康日益成長的興趣，推動了多個消費群體的需求。支持ω-3脂肪酸在心血管健康、認知功能和整體健康方面作用的科學研究，顯著提升了全球消費者的信心和產品接受度。同時，隨著飲食偏好的改變，素食和純素食營養解決方案日益普及，市場正轉向植物來源和永續的ω-3來源。機能性食品和飲料中ω-3成分的日益增多也促進了需求，拓展了傳統膳食補充劑以外的市場機會。食品和飲料製造商正積極將ω-3脂肪酸添加到更廣泛的消費產品中，以提高營養價值並回應消費者日益成長的健康意識。此外，隨著企業尋求傳統原料的永續替代方案，原料來源多元化正成為業界關注的重點。這項轉變正在推動生產技術和整個供應鏈的創新，在整個預測期內為全球 omega-3 脂肪酸市場創造新的成長機會。

預計到2025年，海洋來源的ω-3脂肪酸市場規模將達到23億美元，並在2026年至2035年間以3.5%的複合年成長率成長。由於海洋來源的ω-3脂肪酸天然富含必需脂肪酸，因此該細分市場在ω-3脂肪酸市場中佔據著重要佔有率。這些必需脂肪酸廣泛應用於膳食補充劑、功能性營養產品和藥品領域。同時，隨著消費者日益尋求永續的植物來源營養解決方案，其他ω-3脂肪酸來源也逐漸受到關注。雖然植物來源的ω-3脂肪酸原料對注重成本的消費者仍然具有吸引力，但其功能特性與海洋來源的ω-3脂肪酸有所不同，這影響了它們在某些終端應用領域的採用。

預計到2025年，營養保健品和膳食補充劑市場規模將達到15億美元，佔市場佔有率的44%。此細分市場強勁的市場地位得益於消費者對預防醫學、日常營養支持和天然保健產品日益成長的興趣。產品供應量的增加、消費者意識的提高以及對健康生活方式的日益偏好，都持續推動該細分市場的需求。隨著消費者越來越重視長期健康管理，營養保健品和膳食補充劑產業預計將繼續成為市場成長的主要驅動力。

預計到2025年，北美ω-3脂肪酸市場規模將達到10億美元。該地區憑藉消費者對營養和健康的高度重視、對膳食補充劑的強勁需求以及完善的醫療保健基礎設施，保持著主導地位。消費者對功能性營養、預防性醫療保健策略和高階健康產品的日益關注，持續推動全部區域市場的擴張。此外，ω-3成分擴大被添加到各種健康和營養產品中，進一步增強了該地區的需求，並為市場參與企業創造了新的機會。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章 行業洞察

• 產業生態系分析
  • 供應商情況
  • 利潤率
  • 每個階段增加的價值
  • 影響價值鏈的因素
  • 中斷
• 影響產業的因素
  • 促進因素
  • 產業潛在風險與挑戰
  • 市場機遇
• 成長潛力分析
• 監理情勢
• 波特的分析
• PESTLE分析
• 價格趨勢
  • 按地區
  • 按類型
• 未來市場趨勢
• 技術與創新展望
  • 最新科技趨勢
  • 新興技術
• 專利趨勢
• 貿易統計
  • 主要進口國
  • 主要出口國
• 永續性和環境方面
  • 永續計劃
  • 減少廢棄物策略
  • 生產中的能源效率
  • 具有環保意識的舉措
• 考慮碳足跡

第4章 競爭情勢

• 介紹
• 企業市佔率分析
  • 按地區
    • 北美洲
    • 歐洲
    • 亞太地區
    • LATAM
    • 中東和非洲
• 企業矩陣分析
• 主要市場公司的競爭分析
• 競爭定位矩陣
• 主要進展
  • 併購
  • 夥伴關係和聯盟
  • 新產品發布
  • 業務拓展計劃

第5章 市場估算與預測：依產品類型分類，2022-2035年

• 海洋來源的 Omega-3
  • 魚油
  • 濃縮魚油
  • 磷蝦油和磷脂製劑
  • 其他
• 源自藻類的ω-3
  • 微藻類油
  • 發酵的EPA和DHA
• 植物來源的ω-3（ALA）
  • 亞麻仁油
  • 奇亞籽
  • 其他
• 處方 Omega-3 藥物
• 濃縮/純化形式

第6章 市場估計與預測：依應用領域分類，2022-2035年

• 心血管健康
  • 第一級預防產品
  • 二級預防製劑
  • 血壓管理
  • 預防心律不整
• 高三酸甘油脂血症的治療
  • 高三酸甘油脂血症
  • 中度高三酸高三酸甘油脂血症
• 全面的健康和營養補充劑
  • 每日營養
  • 大腦健康與認知功能
  • 眼睛健康和視力支持
  • 關節健康與炎症
• 機能性食品與營養強化
  • 乳製品
  • 麵包糖果甜點
  • 飲料的營養強化
  • 肉類/家禽
• 嬰幼兒及孕婦/哺乳婦女的營養
  • 嬰兒配方奶粉的用途
  • 懷孕和產後補充劑
  • 兒童營養產品
• 飼料和水產養殖
  • 水產飼料
  • 寵物食品
  • 牲畜飼料

第7章 市場估計與預測：依最終用途產業分類，2022-2035年

• 製藥業
• 營養保健品和膳食補充品產業
• 食品飲料業
• 飼料業

第8章 市場估計與預測：依地區分類，2022-2035年

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲國家
• 中東和非洲
  • 沙烏地阿拉伯
  • 南非
  • UAE
  • 其他中東和非洲國家

第9章：公司簡介

• DSM-Firmenich
• BASF SE
• Croda International
• Aker BioMarine
• Archer Daniels Midland
• Cargill
• Corbion
• Omega Protein Corporation
• Epax
• KD Pharma Group
• Polaris Nutritional Lipids
• Solutex
• Veramaris
• Yield10 Bioscience
• AlgaeCytes
• Fermentalg
• Qualitas Health

The Global Omega-3 Fatty Acids Market was valued at USD 3.5 billion in 2025 and is estimated to grow at a CAGR of 4.1% to reach USD 5.2 billion by 2035.

The omega-3 fatty acids market continues to expand as consumers become increasingly aware of the health benefits associated with these essential nutrients. Growing interest in preventive healthcare, nutritional supplementation, and overall wellness is driving demand across multiple consumer segments. Scientific research supporting the role of omega-3 fatty acids in cardiovascular health, cognitive function, and general well-being has significantly strengthened consumer confidence and product adoption worldwide. At the same time, the market is experiencing a shift toward plant-based and sustainable omega-3 sources as changing dietary preferences encourage the adoption of vegetarian and vegan nutrition solutions. Demand is also being fueled by the increasing incorporation of omega-3 ingredients into functional foods and beverages, extending market opportunities beyond traditional dietary supplements. Food and beverage manufacturers are actively integrating omega-3 fatty acids into a broader range of consumer products to enhance nutritional value and meet evolving health-conscious consumption trends. Additionally, source diversification is becoming a major industry focus as companies seek sustainable alternatives to conventional raw material sources. This transition is encouraging innovation across production technologies and supply chains, creating new growth opportunities throughout the global omega-3 fatty acids market during the forecast period.

The marine-derived omega-3 segment generated USD 2.3 billion in 2025 and is anticipated to grow at a CAGR of 3.5% between 2026 and 2035. This segment continues to hold a substantial share of the omega-3 fatty acids market due to its naturally high concentration of essential fatty acids that are widely utilized in dietary supplements, functional nutrition products, and pharmaceutical applications. Meanwhile, alternative omega-3 sources are gaining momentum as consumers increasingly seek sustainable and plant-based nutritional solutions. Although plant-derived omega-3 ingredients remain attractive to cost-conscious consumers, their functional characteristics differ from marine-based alternatives, influencing their adoption across specific end-use applications.

The nutraceutical and dietary supplement segment accounted for USD 1.5 billion in 2025 and represented 44% share. Its strong market position is supported by rising consumer focus on preventive healthcare, daily nutritional support, and natural wellness products. Expanding product availability, increasing consumer awareness, and a growing preference for health-focused lifestyles continue to drive demand within this segment. As consumers increasingly prioritize long-term health management, the nutraceutical and dietary supplement industry is expected to remain a major contributor to market growth.

North America Omega-3 Fatty Acids Market generated USD 1 billion in 2025. The region maintains a leading position due to high consumer awareness regarding nutritional health, robust demand for dietary supplements, and a well-developed healthcare infrastructure. Growing interest in functional nutrition, preventive healthcare strategies, and premium wellness products continues to support market expansion across the region. In addition, increasing the incorporation of omega-3 ingredients into a wide variety of health and nutrition products is further strengthening regional demand and creating new opportunities for market participants.

Major companies operating in the global omega-3 fatty acids market include DSM-Firmenich, BASF SE, Croda International, Aker BioMarine, Archer Daniels Midland, Cargill, Corbion, Omega Protein Corporation, Epax, KD Pharma Group, Polaris Nutritional Lipids, Solutex, Veramaris, Yield10 Bioscience, AlgaeCytes, Fermentalg, Qualitas Health, and other industry participants. Companies operating in the omega-3 fatty acids market are focusing on innovation, sustainability, and portfolio diversification to strengthen their competitive position. Significant investments in research and development are enabling manufacturers to improve product purity, bioavailability, and formulation effectiveness while addressing evolving consumer preferences. Many companies are expanding their presence in plant-based and alternative omega-3 sources to meet growing demand for sustainable and vegan nutrition products. Strategic partnerships, acquisitions, and collaborations are being utilized to enhance production capabilities, strengthen supply chains, and expand geographic reach. Businesses are also increasing investments in functional food and beverage applications to diversify revenue streams beyond traditional dietary supplements.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/Country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis
• 2.2 Key market trends
  • 2.2.1 Regional
  • 2.2.2 Product Type
  • 2.2.3 Application
  • 2.2.4 End Use Industry
• 2.3 TAM Analysis, 2026-2035
• 2.4 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Supplier landscape
  • 3.1.2 Profit margin
  • 3.1.3 Value addition at each stage
  • 3.1.4 Factor affecting the value chain
  • 3.1.5 Disruptions
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
  • 3.2.2 Industry pitfalls and challenges
  • 3.2.3 Market opportunities
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
  • 3.4.4 Latin America
  • 3.4.5 Middle East & Africa
• 3.5 Porter's analysis
• 3.6 PESTEL analysis
• 3.7 Price trends
  • 3.7.1 By region
  • 3.7.2 By type
• 3.8 Future market trends
• 3.9 Technology and Innovation landscape
  • 3.9.1 Current technological trends
  • 3.9.2 Emerging technologies
• 3.10 Patent Landscape
• 3.11 Trade statistics (HS code)
  • 3.11.1 Major importing countries
  • 3.11.2 Major exporting countries
• 3.12 Sustainability and environmental aspects
  • 3.12.1 Sustainable practices
  • 3.12.2 Waste reduction strategies
  • 3.12.3 Energy efficiency in production
  • 3.12.4 Eco-friendly initiatives
• 3.13 Carbon footprint consideration

Chapter 4 Competitive Landscape, 2025

• 4.1 Introduction
• 4.2 Company market share analysis
  • 4.2.1 By region
    • 4.2.1.1 North America
    • 4.2.1.2 Europe
    • 4.2.1.3 Asia Pacific
    • 4.2.1.4 LATAM
    • 4.2.1.5 MEA
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New Product Launches
  • 4.6.4 Expansion Plans

Chapter 5 Market Estimates and Forecast, By Product Type, 2022-2035 (USD Billion) (Kilo Tons)

• 5.1 Key trends
• 5.2 Marine-derived omega-3
  • 5.2.1 Fish oil
  • 5.2.2 Concentrated fish oil
  • 5.2.3 Krill oil & phospholipid forms
  • 5.2.4 Others
• 5.3 Algal-derived omega-3
  • 5.3.1 Microalgae oil
  • 5.3.2 Fermentation-derived EPA & DHA
• 5.4 Plant-based omega-3 (ala)
  • 5.4.1 Flaxseed oil
  • 5.4.2 Chia seed oil
  • 5.4.3 Others
• 5.5 Prescription omega-3 drugs
• 5.6 Concentrated & purified forms

Chapter 6 Market Estimates and Forecast, By Application, 2022-2035 (USD Billion) (Kilo Tons)

• 6.1 Key trends
• 6.2 Cardiovascular health
  • 6.2.1 Primary prevention products
  • 6.2.2 Secondary prevention formulations
  • 6.2.3 Blood pressure management
  • 6.2.4 Arrhythmia prevention
• 6.3 Hypertriglyceridemia treatment
  • 6.3.1 Severe hypertriglyceridemia
  • 6.3.2 Moderate hypertriglyceridemia
• 6.4 General wellness & dietary supplements
  • 6.4.1 Daily nutrition
  • 6.4.2 Brain health & cognitive function
  • 6.4.3 Eye health & vision support
  • 6.4.4 Joint health & inflammation
• 6.5 Functional foods & fortification
  • 6.5.1 Dairy product
  • 6.5.2 Bakery & confectionery
  • 6.5.3 Beverage fortification
  • 6.5.4 Meat & poultry
• 6.6 Infant & maternal nutrition
  • 6.6.1 Infant formula applications
  • 6.6.2 Prenatal & postnatal supplements
  • 6.6.3 Pediatric nutrition products
• 6.7 Animal feed & aquaculture
  • 6.7.1 Aquaculture feed
  • 6.7.2 Pet food
  • 6.7.3 Livestock feed

Chapter 7 Market Estimates and Forecast, By End Use Industry, 2022-2035 (USD Billion) (Kilo Tons)

• 7.1 Key trends
• 7.2 Pharmaceutical industry
• 7.3 Nutraceutical & dietary supplement industry
• 7.4 Food & beverage industry
• 7.5 Animal feed industry

Chapter 8 Market Estimates and Forecast, By Region, 2022-2035 (USD Billion) (Kilo Tons)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 India
  • 8.4.3 Japan
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 South Africa
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 DSM-Firmenich
• 9.2 BASF SE
• 9.3 Croda International
• 9.4 Aker BioMarine
• 9.5 Archer Daniels Midland
• 9.6 Cargill
• 9.7 Corbion
• 9.8 Omega Protein Corporation
• 9.9 Epax
• 9.10 KD Pharma Group
• 9.11 Polaris Nutritional Lipids
• 9.12 Solutex
• 9.13 Veramaris
• 9.14 Yield10 Bioscience
• 9.15 AlgaeCytes
• 9.16 Fermentalg
• 9.17 Qualitas Health